Correlation Between Merck and Fidelity Series

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck and Fidelity Series at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Fidelity Series into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Fidelity Series Growth, you can compare the effects of market volatilities on Merck and Fidelity Series and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Fidelity Series. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Fidelity Series.

Diversification Opportunities for Merck and Fidelity Series

-0.84
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Merck and Fidelity is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Fidelity Series Growth in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fidelity Series Growth and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Fidelity Series. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fidelity Series Growth has no effect on the direction of Merck i.e., Merck and Fidelity Series go up and down completely randomly.

Pair Corralation between Merck and Fidelity Series

Considering the 90-day investment horizon Merck Company is expected to under-perform the Fidelity Series. In addition to that, Merck is 1.11 times more volatile than Fidelity Series Growth. It trades about -0.16 of its total potential returns per unit of risk. Fidelity Series Growth is currently generating about 0.13 per unit of volatility. If you would invest  2,545  in Fidelity Series Growth on August 24, 2024 and sell it today you would earn a total of  89.00  from holding Fidelity Series Growth or generate 3.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Merck Company  vs.  Fidelity Series Growth

 Performance 
       Timeline  
Merck Company 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Fidelity Series Growth 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Fidelity Series Growth are ranked lower than 7 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Fidelity Series may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Merck and Fidelity Series Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck and Fidelity Series

The main advantage of trading using opposite Merck and Fidelity Series positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Fidelity Series can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fidelity Series will offset losses from the drop in Fidelity Series' long position.
The idea behind Merck Company and Fidelity Series Growth pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules